306 related articles for article (PubMed ID: 23682607)
1. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
Große K; Schmidt RE; Witte T; Baerlecken NT
Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
[TBL] [Abstract][Full Text] [Related]
2. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
Baerlecken NT; Linnemann A; Gross WL; Moosig F; Vazquez-Rodriguez TR; Gonzalez-Gay MA; Martin J; Kötter I; Henes JC; Melchers I; Vaith P; Schmidt RE; Witte T
Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484
[TBL] [Abstract][Full Text] [Related]
3. Association of ferritin antibodies with Takayasu arteritis.
Große K; Witte T; Moosig F; Hoyer BF; Lansche C; Schmidt RE; Baerlecken NT
Clin Rheumatol; 2014; 33(10):1523-6. PubMed ID: 25178778
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
[TBL] [Abstract][Full Text] [Related]
7. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
Dababneh A; Gonzalez-Gay MA; Garcia-Porrua C; Hajeer A; Thomson W; Ollier W
J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
9. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
10. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
11. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
12. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
[TBL] [Abstract][Full Text] [Related]
13. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
[TBL] [Abstract][Full Text] [Related]
14. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
[TBL] [Abstract][Full Text] [Related]
15. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
16. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune aspects of giant cell arteritis.
Nesher G
Isr Med Assoc J; 2014 Jul; 16(7):454-5. PubMed ID: 25167695
[TBL] [Abstract][Full Text] [Related]
19. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population.
Combe B; Sany J; Le Quellec A; Clot J; Eliaou JF
J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210
[TBL] [Abstract][Full Text] [Related]
20. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
